Ecstasy in the brain: A model for neuroimaging

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 14, Issue 2, 2002, Pages 125-129

  Hurley, Robin A ^a   Reneman, Liesbeth ^a   Taber, Katherine H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN RECEPTOR;

ARTICLE; BRAIN; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ABUSE; HUMAN; MEMORY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

EID: 0036264674     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.14.2.125     Document Type: Article

References (31)

1. Effects of ecstasy (MDMA) on the brain in abstinent users: Initial observations with diffusion and perfusion MR imaging
2. Designer drugs: Assess and manage patients intoxicated with ecstasy, GHB or rohypnol - The three most commonly abused designer drugs
3. Ecstasy (MDMA): A review of its possible persistent psychological effects
4. The many faces of ecstasy
5. Chemical analysis of ecstasy pills
6. Amphetamine designer drugs: An overview and epidemiology
7. Ecstasy is a dangerous drug
8. Drug use and life style among college undergraduates: A 30-year longitudinal study
9. Adam (MDMA) and Eve (MDEA) misuse: An immunohistochemical study on three fatal cases
10. Death from hyponatraemia-induced cerebral oedema associated with MDMA ("Ecstasy") use
11. Fatal MDMA intoxication
12. (+/-)3,4-Methylenedioxymethamphetamine ("Ecstasy")-induced serotonin neurotoxicity: Studies in animals
13. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: A co-registered SPECT and MRI study
14. Acute inflammatory CNS disease after MDMA ("ecstasy")
15. Toxic leukencephalopathy following "ecstasy" ingestion
16. A pure amnestic syndrome after MDMA ("ecstasy") ingestion
17. Cerebral (1)H MRS alterations in recreational 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users
18. Reduced N-acetyl-aspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (ecstasy) users: Preliminary results
19. "Ecstasy"-induced changes of cerebral glucose metabolism and their correlation to acute psychopathology: An 18-FDG PET study
20. Ecstasy: Long-term effects on the human central nervous system revealed by positron emission tomography
21. Long-term effects of "ecstasy" abuse on the human brain studied by FDG PET
22. 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humans
23. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: A [H2(15)O]-positron emission tomography study
24. MDMA ("Ecstasy") and its association with cerebrovascular accidents: Preliminary findings
25. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission
26. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users
27. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons
28. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): Preliminary findings
29. Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings
30. "Ecstasy" and serotonin neurotoxicity: New findings raise more questions
31. Ecstasy research okayed